Danielle H. Dube, Ph.D.
Affiliations: | 2008- | Chemistry | Bowdoin College, Brunswick, ME, United States |
Area:
Chemical BiologyWebsite:
https://www.bowdoin.edu/faculty/d/ddube/Google:
"Danielle Dube"Mean distance: 8.03 | S | N | B | C | P |
Parents
Sign in to add mentor| Carolyn R. Bertozzi | grad student | 2005 | UC Berkeley | |
| (Probing glycosylation using azidosugars and the Staudinger ligation in vivo.) | ||||
| David V. Schaffer | grad student | 2005 | UC Berkeley | |
| (Probing glycosylation using azidosugars and the Staudinger ligation in vivo.) | ||||
| Jennifer J. Kohler | post-doc | 2005-2007 | Stanford | |
Children
Sign in to add trainee| Pornchai Kaewsapsak | research assistant | Bowdoin College (Cell Biology Tree) | |
| Scott A. Longwell | research assistant | 2010-2013 | Bowdoin College |
| Van N. Tra | research assistant | 2014 | Bowdoin College |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Quintana IL, Paul A, Chowdhury A, et al. (2023) Thioglycosides Act as Metabolic Inhibitors of Bacterial Glycan Biosynthesis. Acs Infectious Diseases |
| Barrett K, Dube DH. (2022) Chemical tools to study bacterial glycans: a tale from discovery of glycoproteins to disruption of their function. Israel Journal of Chemistry. 63 |
| Luong P, Dube DH. (2021) Dismantling the bacterial glycocalyx: Chemical tools to probe, perturb, and image bacterial glycans. Bioorganic & Medicinal Chemistry. 42: 116268 |
| Williams DA, Pradhan K, Paul A, et al. (2020) Metabolic inhibitors of bacterial glycan biosynthesis. Chemical Science. 11: 1761-1774 |
| Moulton KD, Adewale AP, Carol HA, et al. (2020) Metabolic Glycan Labeling-Based Screen to Identify Bacterial Glycosylation Genes. Acs Infectious Diseases |
| Williams DA, Pradhan K, Paul A, et al. (2020) Metabolic inhibitors of bacterial glycan biosynthesis Chemical Science. 11: 1761-1774 |
| Epstein TD, Wu B, Moulton KD, et al. (2019) Sugar-modified analogs of auranofin are potent inhibitors of the gastric pathogen . Acs Infectious Diseases |
| Clark EL, Emmadi M, Krupp KL, et al. (2016) Development of rare bacterial monosaccharide analogs for metabolic glycan labeling in pathogenic bacteria. Acs Chemical Biology |
| Tra VN, Dube DH. (2014) Glycans in pathogenic bacteria--potential for targeted covalent therapeutics and imaging agents. Chemical Communications (Cambridge, England). 50: 4659-73 |
| Champasa K, Longwell SA, Eldridge AM, et al. (2013) Targeted identification of glycosylated proteins in the gastric pathogen Helicobacter pylori (Hp). Molecular & Cellular Proteomics : McP. 12: 2568-86 |